yahoo_financeOriginal article
Quince Therapeutics Announces Clinically Meaningful Improvements Across Functional, Hemodynamic and Biomarker Measures in Phase 2 Study in PAH and PH-ILD
Phase 2positivePositive
AI Analysis
Summary
Quince Therapeutics announced positive Phase 2 study results showing clinically meaningful improvements across functional, hemodynamic, and biomarker measures in patients with PAH and PH-ILD.
Clinical Trial Data
Phase
2
Primary Endpoint
Met
Outcome Details
Clinically meaningful improvements across functional, hemodynamic and biomarker measures
Importance:6/10
Sentiment:
0.75
Phase 2PAHPH-ILDPulmonary HypertensionClinical Trial
Related Companies
Read the original article
Published by yahoo_finance on May 18, 2026 1:26 PM